STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  by Chen, Xiangmei et al.
Kidney International, Vol. 64 (2003), pp. 459–467
STAT proteins mediate angiotensin II–induced production of
TIMP-1 in human proximal tubular epithelial cells
XIANGMEI CHEN, JIANZHONG WANG, FENG ZHOU, XIAODAN WANG, and ZHE FENG
Department of Nephrology, Chinese General Hospital of PLA, Beijing, China
STAT proteins mediate angiotensin II–induced production of
TIMP-1 in human proximal tubular epithelial cells.
Background. Angiotensin II and tissue type inhibitor metal-
loproteinase-1 (TIMP-1) have been implicated in renal tubulo-
interstitial fibrosis, but the exact mediating signaling pathway
is still unknown. Angiotensin II has been reported to activate
signal transducers and activators of transcription (STAT) and
induce proliferation of myocyte and vascular smooth muscle
cells (VSMC). We hypothesized that the STAT signal pathway
is involved in the process of renal tubulointerstitial fibrosis.
Therefore, we designed the present study to explore whether
angiotensin II could induce TIMP-1 expression in human proxi-
mal tubular epithelial cells, and whether it was mediated
through the STAT signaling pathway.
Methods. Electrophoretic mobility shift assay (EMSA) was
employed to determine the DNA-STAT binding activity. Su-
pershift assay was used to test the components of activated
STAT proteins. Nuclear translocation of activated STATs was
observed with laser scanning confocal microscopy. TIMP-1 ex-
pression was analyzed with Northern and Western blots. Val-
sartan and PD123319 were used to block the effects of angio-
tensin II type 1 (AT1) and angiotensin II type 2 (AT2)
receptors of angiotensin II, respectively.
Results. Cultured human proximal tubular epithelial cells
constitutively expressed TIMP-1. Angiotensin II induced TIMP-1,
mRNA, and protein expressions in time- and dose-dependent
manners, which could be inhibited by the AT1 receptor antago-
nist valsartan, but not by the AT2 antagonist PD123319. Angio-
tensin II also activated STAT-DNA binding activity in both
dose-dependent and biphasic time-dependent manners, and in-
creased the phosphorylation and nuclear translocation of STAT
proteins. To examine the role of STAT in angiotensin II–
induced TIMP-1 expression, STAT1 and STAT3 antisense oli-
gonucleotides were used. Northern and Western blots showed
that STAT1 and STAT3 antisense oligonucleotides could in-
hibit angiotensin II–induced TIMP-1 expressions, and STAT1
and STAT3 proteins, respectively, could be supershifted by
their polyclonal antibodies.
Conclusion. STAT1 and STAT3 may, at least in part, medi-
ate angiotensin II–induced TIMP-1 mRNA expression in hu-
man renal proximal tubular epithelial cells, implicating a role
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of the STAT signaling pathway in pathogenesis of renal tubulo-
interstitial fibrosis.
The renin-angiotensin system (RAS) plays an integral
role in both cardiovascular and renal homeostasis by
influencing blood pressure, fluids and electrolytes, and
the sympathetic nervous system [1, 2]. It has been dem-
onstrated that RAS also plays a pivotal role in the pro-
gression of renal diseases [3, 4]. Angiotensin II not only
stimulates proliferation of renal resident cells, but also pro-
motes accumulation of the extracellular matrix (ECM),
leading to glomerulosclerosis and tubulointerstitial fi-
brosis [3, 4]. Biological actions of the highly active octa-
peptide, angiotensin II, are mediated mainly through
receptor subtype angiotensin II type 1 (AT1), which tightly
associates with intracellular signal transduction pathways
[5]. Janus kinase-signal transducer and activator of tran-
scription (JAK-STAT), an important signal transduction
pathway, has been implicated in some angiotensin II–
induced biological actions [6].
Angiotensin II has been well known to initiate multi-
ple signaling pathways via its receptors [5]. It has been
found that angiotensin II could induce the production
of tissue inhibitor metalloproteinase-1 (TIMP-1), an im-
portant member of TIMP family, which is responsible for
inhibition of matrix metalloproteinases (MMPs), which
regulate ECM degradation in rat heart endothelial cells
[7]. However, little is known about whether angiotensin
II could induce TIMP-1 expression in renal cells and
which signaling pathway is involved in angiotensin II–
induced TIMP-1 expression. Angiotensin II has been
reported to activate signal transducer and activator of
transcription (STAT) and promote proliferation of myo-
cytes and vascular smooth muscle cells (VSMC). Re-
cently we reported that STAT1 and STAT3 mediated
thrombin-induced up-regulation of TIMP-1 in human
glomerular mesangial cells [8].
From the above, we hypothesized that the STAT signal
pathway is involved in the process of renal tubulointersti-
tial fibrosis; this present study was designed to further
explore whether STAT proteins mediated angiotensin II–
induced expression of TIMP-1 in human renal proximal
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tubular epithelial cells, and to provide evidence of the
STAT signaling pathway in the pathogenesis of renal
fibrosis.
METHODS
Cell line and main reagents
Human renal proximal tubular epithelial cell line,
HK-2, was an immortalized cell line purchased from
American Type Culture Collection (ATCC, CRL-2190)
[9]. Rabbit polyclonal STAT1 antibody (Sc-345X), rabbit
polyclonal STAT3 antibody (Sc-482X), mouse mono-
clonal STAT1 antibody (Sc-8394), mouse monoclonal
STAT3 antibody (Sc-8095), and monkey anti-rabbit im-
munoglobulin G (IgG)/horseradish-peroxidase (HRP)
(Sc-2757) were purchased from Santa Cruz Biotechnol-
ogy, Inc. (Santa Cruz, CA, USA). Angiotensin II and
valsartan were purchased from Amersham Biosciences,
Inc. (San Francisco, CA, USA), and PD123319 was pur-
chased from Research Biochemicals International (Na-
tick, MA, USA). Goat anti-mouse IgG/HRP (ZF-0312)
was from Zhongshan Biotechnology, Inc. (Beijing, China),
and -32P adenosine triphosphate (ATP) and -32P carba-
mylated protein (CTP) were purchased from Beijing Yahui
Biotechnology Engineering Company (Beijing, China).
The electrophoretic mobility shift assay (EMSA) reagent
kit was bought from Promega, Inc. (Fitchburg, WI, USA),
and the isotope labeling kit from Roche, Inc. (Basel, Swit-
zerland). STAT probes were synthesized by Shanghai
Biology Engineering Company (Shanghai, China).
Cell culture
Human renal proximal tubular epithelial cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (vol/vol) fetal calf serum (FCS),
100 L/mL penicillin, 100 g/mL streptomycin at 37C
in 5% CO2. The cells at 80% confluence were deprived
of serum for 12 hours, and then stimulated with angioten-
sin II in a serum-free RPMI1640 medium for 2 to 3 hours.
The final concentrations of angiotensin II were 109 mol/L,
108 mol/L, 107 mol/L, and 106 mol/L, respectively. The
final concentration of valsartan, a specific antagonist of
AT1 receptor, was 106 mol/L, and the final concentra-
tion of PD123319, a specific inhibitor of AT2 receptor,
was 106 mol/L. For time course assays, cells were har-
vested after incubation with angiotensin II (107 mol/L)
for 10, 30, 60, 120, and 180 minutes, respectively.
Antisense oligodeoxynucleotide studies
Phosphorothioated 21-mer oligodeoxynucleotides for
STAT1 and STAT3 were synthesized on an Applied Bio-
system 394 synthesizer by means of -cyanothylphysphor-
amidite chemistry to minimize degradation of the oligo-
nucleotides by endogenous nucleases. The antisense oligo-
nucleotides were directed against the translation start
site (AUG codon) and surrounding nucleotides of the
human STAT1 and STAT3 genes, respectively [10]. The
STAT1 antisense oligonucleotide sequence was 5-CCA
CTG AGA CAT CCT GCC ACC-3 and the correspond-
ing sense oligonucleotide sequence was 5-GGT GGC
AGG ATG TCT CAG TGG-3. The STAT 3 antisense
oligonucleotide sequence was 5-CCA TTG GGC CAT
CCT GTT TCT-3 and the corresponding sense oligonu-
cleotide sequence was 5-AGA AAC AGG ATG GCC
CAA TGG-3. In addition, the scrambled oligonucleotide
sequence was CAA ATG GGC TCC GAC GTC GGT.
In order to evaluate the role of STAT1 and STAT3
in angiotensin-induced TIMP-1 expression, subconfluent
HK-2 cells were deprived of serum for 12 hours, followed
by changing the medium to serum-free DMEM con-
taining 3 mol antisense oligonucleotides in 10 mg/mL
lipofectin and incubated for 10 hours before adding an-
giotensin II. As control, cells received serum-free DMEM
medium containing lipofectin with or without 3 mol/L
sense or scrambled oligonucleotides.
Preparation of nuclear proteins
Nuclear proteins were extracted with the method pre-
viously described [8]. Briefly, cells were rinsed twice with
cold phosphate-buffered saline (PBS), scraped with a rub-
ber policeman, and transferred to microcentrifuge tubes.
Cell pellets were suspended in 400 L cold buffer A [10
mmol/L N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid (HEPES) pH 7.9, 1.5 mmol/L MgCl2, 10 mmol/L
KCl, 0.5 mmol/L dithioreitol (DTT), 0.2 mmol/L phenyl-
methylsulfonyl fluoride (PMSF)] and left on ice for effi-
cient cell swelling, followed by a centrifugation for 10
seconds. Nuclear pellets were suspended again in 40 L
cold buffer C [20 mmol/L HEPES pH 7.9, 25% glycerol,
420 mmol/L NaCl, 1.5 mmol/L MgCl2, 0.2 mmol/L ethyl-
enediaminetetraacetic acid (EDTA), 0.5 mmol/L DTT,
0.2 mmol/L PMSF] and incubated on ice for 30 minutes.
After a centrifugation at 12,000 rpm for 2 minutes at
4C, the concentrations of the supernatant proteins were
determined. Aliquots of the nuclear proteins were stored
at 70C until use.
Electrophoretic mobility shift assay (EMSA)
EMSA was carried out following the method pre-
viously described [8]. Briefly, the STAT-binding double-
stranded consensus oligonucleotide probe used in this
study was m67 (5-CATTTCCCGTAAATC-3), which
can bind both STAT1 and STAT3 [11]. The probe was
end-labeled with -32P-ATP by T4 polynucleotide ki-
nase (Gibco-BRL, Gaithersburg, MD, USA) according
to the manufacturer’s protocol. For binding reactions,
50,000 cpm of the end-labeled STAT1- or STAT3-bind-
ing probe was incubated with a cocktail of 20 g nuclear
proteins in gel shift binding buffer (10 mmol Tris-HCl
pH 7.5, 50 mmol NaCl, 4% glycerol, 1.0 mmol MgCl2,
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5.0 mmol EDTA, 0.5 mmol DTT) and 2 g poly (dI-dC)
at room temperature for 30 minutes. EMSAs were per-
formed on nondenaturing 4% polyacrylamide gel in 0.5
Tris-borate EDTA (TBE) buffer at 100 V. Dried gels
were subjected to autoradiography at 70C. For speci-
ficity test, unlabeled STAT-binding oligonucleotides at
50-fold molar excess were added 30 minutes before the
addition of the labeled. As the negative control, unla-
beled nuclear factor kappa B (NF	B)-binding oligonu-
cleotides at 50-fold molar excess were also included. For
supershift assays, nuclear extracts were preincubated
with STAT1 polyclonal antibody or STAT3 polyclonal
antibody for 30 minutes on ice before addition of the
probe.
Western blotting assay
For analysis of activated STAT proteins, the renal
proximal tubular epithelial cells were deprived of serum
for 12 hours and, when reaching 80% confluence, chal-
lenged with 107 mol angiotensin II with or without AT1/
AT2 receptor antagonist for 3 hours. The cells were then
put on ice, rinsed with ice-cold PBS, and scraped with
a rubber policeman from the flasks in 1 sodium dodecyl
sulfate (SDS) loading buffer. Supernatants were cleared
of cell fragments by centrifugation and protein concen-
tration determined by Coumassie bright blue assay. The
sample proteins, or the STAT1/STAT3 phosphorylation
positive control (Sc2222, Santa Cruz Biotechnology) was
mixed with an equal volume of sample buffer, boiled for 5
minutes, electrophoresed on a 12% SDS-polyacrylamide
gel for 60 minutes at room temperature, and transferred
to nitrocellulose filters (Amersham Pharmacia Biotech).
The membrane was blocked with Tris-buffered saline
Tween-20 (TTBS) solution containing 3% bovine serum
albumin (BSA), incubated with mouse monoclonal anti-
STAT1/3 and rabbit polyclonal anti-STAT1/3, washed
in Tris buffered saline with 0.1% Tween (TBST), and
incubated with HRP-coupled second anti-mouse (Amer-
sham Pharmacia Biotechnology) or anti-rabbit antibody
(Santa Cruz Biotechnology) for 45 minutes in TBST/
0.05% BSA. Immunoreactive bands were visualized with
enhanced chemiluminescence (ECL) system.
For analysis of effects of angiotensin II on TIMP-1
protein expression, cells were harvested after incubation
with angiotensin II and/or its receptors’ antagonists for 3
hours. As for the effects of STAT1 and STAT3 antisense
oligonucleotides on TIMP-1 protein abundance induced
by angiotensin II, the cells were incubated in serum-free
DMEM medium containing 3mol antisense oligonucle-
otides in 10 mg/mL lipofectin for 10 hours before incuba-
tion with angiotensin II for 3 hours. As control, the cells
were treated with serum-free DMEM medium con-
taining lipofectin with or without 3 mol sense oligonu-
cleotides or scrambled oligonucleotides. The sample pro-
tein was mixed with an equal volume of sample buffer,
boiled for 5 minutes, electrophoresed on a 12% SDS-
polyacrylamide gel for 60 minutes at room temperature,
and transferred to nitrocellulose filters (Amersham Phar-
macia Biotechnology). The membrane was blocked with
TTBS solution containing 3% BSA, incubated with mouse
monoclonal antibodies against human TIMP-1 dilution
of 1:200 at room temperature for 60 minutes, and binding
was detected by the use of HRP-conjugated secondary
antibody system.
Laser scanning confocal microscope observation
The experiment was carried out according to the meth-
od with modification [12]. Briefly, HK-2 cells were cul-
tured on 8-well chamber slides, deprived of serum for
13 hours after reaching 80% confluence, treated with
angiotensin II for 3 hours, then washed in PBS and fixed
with 4% paraformaldehyde. After being blocked with
1% BSA in PBS/0.01% saponin, the cells were incubated
with mouse anti-STAT1 and anti-STAT3 antibody in
PBS in 0.1% BSA/0.1% saponin (1:100 dilution). After
washing with PBS in 0.1% BSA/0.1% saponin, the cells
were incubated with fluoroscein isothiocyanate (FITC)-
labeled goat anti-mouse IgG in PBS with 0.1% BSA/
0.1% saponin, and observed under a Bio-Rad (Radiance
2000; Bio-Rad, Hercules, CA, USA) laser scanning con-
focal microscope.
Northern blot analysis of Ang II–induced TIMP-1
mRNA expression
Total RNA was extracted with Trizol reagent (Gibco-
BRL) according to the manufacturer’s instructions.
Briefly, the cells were rinsed with cold PBS solution three
times, mixed with 0.8 mL Trizol solution in the flask,
stood on ice for 15 minutes, transferred into sterile cen-
trifugation tubes, mixed with chloroform, and centri-
fuged at 12,000 rpm for 15 minutes at 4C. The upper
transparent layer was transferred to another centrifuge
tube and mixed with equal volumes of isopropanol, fol-
lowed by centrifugation again at 4C. The RNA pellets
were dissolved in diethyl pyrocarbonate (DEPC)-treated
water and quantified with spectrophotometer. Total RNA
(20 g) was electrophoresed on 1% agarose gel con-
taining 2.2% formaldehyde and transferred onto nylon
membrane (Hybond, Amersham) by capillary blotting,
crosslinked in an ultraviolet crosslinker, prehybridized,
and then hybridized with 32P-labeled human TIMP-1
probe. The probe was prepared by reverse transcription-
polymerase chain reaction (RT-PCR). The primers used
for RT-PCR are as follows: human TIMP-1 sense se-
quence: 5-TTG AAT TCC CAC CAT GGC CCC CTT
TGA GCC-3; antisense: 5-GCA GGA TTC AGG CTA
TCT GGG ACC GCA-3. The PCR products were puri-
fied with glassmilk (Bio-Rad) and identified with DNA
sequencing.
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Statistics
All data provided were shown as mean 
 SD from at
least five separate experiments. Differences were evalu-
ated with one way analysis of variance (ANOVA) fol-
lowed by t test. Statistical significance was defined as
P  0.05.
RESULTS
Angiotensin II–induced TIMP-1 mRNA expression
Human renal proximal tubular epithelial HK-2 cells
constitutively expressed TIMP-1 at both mRNA and pro-
tein levels. Angiotensin II increased TIMP-1 mRNA and
protein expressions in both dose- and time-dependent
manners, which could be inhibited by the AT1 receptor
antagonist, valsartan, but not by AT2 receptor antagonist
PD123319 (Figs. 1 and 2). Both mRNA and protein ex-
pressions of TIMP-1 peaked at 3 hours of incubation in
cells treated with 107 mol angiotensin II (Fig. 2).
Angiotensin II–stimulated phosphorylation and
nuclear translocation of STAT proteins
Western blotting analysis demonstrated that angioten-
sin II increased the phosphorylation of both STAT1 and
STAT3 proteins significantly (Fig. 3 and 4). Laser scan-
ning confocal microscopy further showed that nuclear
translocations of both STAT1 and STAT3 were in-
creased by angiotensin II (Fig. 5). The above phosphory-
lations and nuclear translocations of STAT1 and STAT3
proteins could be suppressed by the AT1 receptor antag-
onist valsartan, but not by the AT2 receptor antagonist
PD123319 (Figs. 3, 4, and 5).
Angiotensin II–stimulated STAT-DNA
binding activity
To explore the possible participation of STATs in angio-
tensin II–induced TIMP-1 gene expression, EMSA was
performed investigating the activity of STAT proteins
in human renal proximal tubular epithelial cells treated
with or without angiotensin II. The results showed that
angiotensin II promoted STAT-DNA binding activity in
both dose- and time-dependent manners, and that angio-
tensin II–induced STAT-DNA binding activity peaked
twice at 10 minutes and 120 minutes of incubation, re-
spectively (Figs. 6 and 7). The outcome of applying cold
or mutant competitor probes supported the specificity
of the m67 probe used (Fig. 8). Supershift assay demon-
strated that the sis-inducing factor (SIF) bands consisted
of both STAT1 and STAT3 proteins (Fig. 9). Receptor
blocking experiments showed that angiotensin II–induced
STAT-DNA binding activity could be blocked by the
AT1 receptor antagonist valsartan, but not by the AT2
receptor antagonist PD123319 (Fig. 10).
Fig. 1. Angiotensin II induced tissue type inhibitor metalloproteinase-1
(TIMP-1), mRNA, and protein expressions in a dose-dependent manner
in human renal proximal tubular epithelial cells. (A ) Representative
Northern blotting results. (B ) Density ratio of TIMP-1 to-actin mRNA
expressions. (C ) Representative Western blotting results. Cells were
harvested after being incubated with angiotensin II and/or its receptors’
antagonists for 3 hours. Lanes 1 to 5 show cells incubated with angioten-
sin II at 0 mol/L, 109 mol/L, 108 mol/L, 107 mol/L, and 106 mol/L,
respectively; lane 6 shows cells treated with angiotensin II 107 mol/L
plus AT1 receptor antagonist valsartan and lane 7 shows cells incubated
with angiotensin II 107 mol/L plus AT2 receptor antagonist PD123319.
N  6 in each concentration group. The data are shown as mean 

SD. *P  0.05 vs. groups 1, 2, and 6.
Role of STAT 1 and STAT 3 in angiotensin
II–induced TIMP-1 mRNA and protein expressions
To further identify the relationship between STAT
activity and TIMP-1 expressions of mRNA and protein,
inhibitory experiments were carried out in this study.
The role of angiotensin II in increasing TIMP-1 expres-
sions of mRNA and protein in human renal proximal
tubular epithelial cells was inhibited by preincubation of
the cells with STAT1 or STAT3 antisense oligonucleo-
tides. STAT1 or STAT3 sense or scrambled oligonucleo-
tides had no effect on TIMP-1, mRNA, and protein ex-
pressions (Fig. 11).
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Fig. 2. Angiotensin II induced tissue type inhibitor metalloproteinase-1
(TIMP-1), mRNA, and protein expressions in a time-dependent man-
ner. (A ) Representative Northern blotting results. (B ) Density ratio
of TIMP-1 to -actin mRNA expressions. (C ) Representative Western
blotting results. Cells were harvested after being incubated with angio-
tensin II (107 mol/L) for 0 minutes (lane 1), 10 minutes (lane 2), 30
minutes (lane 3), 1 hour (lane 4), 2 hours (lane 5), 3 hours (lane 6),
and 4 hours (lane 7), respectively. N  6 in each group. The data are
shown as mean 
 SD. *P  0.05 vs. groups 1, 2, and 3.
DISCUSSION
The kidney is the main organ responsible for homeo-
stasis of fluids and electrolytes in which proximal tubular
epithelial cells bear important physiologic functions of
reabsorption and secretion [1, 2]. Besides this, renal tu-
bular epithelial cells can express major histocompatibil-
ity complex II (MHC II) antigens and participate in
inflammation and structure remodeling through produc-
tion of transforming growth factor-1 (TGF-1) to pro-
mote the transdifferentiation of proximal tubular cells
to fibroblasts and accumulation of ECM [13, 14].
Renal tubular epithelial cells are also able to regulate
ECM metabolism by producing both matrix metallopro-
teinases (MMPs) and TIMPs. Imbalance between MMPs
and TIMPs may lead to ECM accumulation under patho-
physiologic conditions [15–18], among which TIMP-1 is
a key inhibitor of MMPs. TIMP-1 can be produced by
virtually all mesenchymal tissues, including intrinsic glo-
Fig. 3. Western blotting analysis of signal transducers and activators
of transcription (STAT1) activation by receptors of angiotensin II. Cells
were harvested after being incubated with angiotensin II for 3 hours.
Lane 1 shows positive control; lane 2 shows 0 mol/L Ang II; lane 3
shows 107 mol/L Ang II; lane 4 shows 107 mol/L Ang II plus 106
mol/L valsartan; and lane 5 shows 107 mol/L angiotensin II plus 106
mol/L PD123319. N  6 in each group. The data are shown as mean 

SD. *P  0.05 vs. groups 3 and 5. P-STAT1 is phosphorylated STAT1
protein.
Fig. 4. Western blotting analysis of STAT3 activation by receptors of
angiotensin II. Cells were harvested after being incubated with angioten-
sin II for 3 hours. Lane 1 shows positive control; lane 2 shows 0 mol/L
angiotensin II; lane 3 shows 107 mol/L angiotensin II; lane 4 shows
107 mol/L angiotensin II plus 106 mol/L valsartan; and lane 5 shows
107 mol/L angiotensin II plus 106 mol/L PD123319. N  6 in each
group. The data are shown as mean 
 SD. *P  0.05 vs. groups 3 and
5. P-STAT3 is phosphorylated STAT3 protein.
merular (mesangial cells and capillary endothelium) and
inflammatory cells such as macrophages and fibroblasts,
and has been reported in facilitating ECM accumulation
and tubulointerstitial fibrosis [19–21]. TIMP-1 expres-
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Fig. 5. Angiotensin II–induced nuclear trans-
locations of activated STAT1 and STAT3 pro-
teins (800). After being incubated with an-
giotensin II for 3 hours, the cells underwent
immunofluorescent staining and were ob-
served by means of laser scanning confocal
microscopy. Column 1 represents 0 mol/L Ang
II; column 2 represents 107 mol/L Ang II;
column 3 represents 107 mol/L Ang II plus
106 mol/L valsartan; and column 4 represents
107 mol/L Ang II plus 106 mol/L PD123319.
STAT is signal transducer and activator of
transcription.
Fig. 6. Angiotensin II induced DNA-STAT binding in a dose-depen-
dent manner. Cells were harvested after being incubated with angioten-
sin II for 3 hours. Lanes 1 through 5 depict cells incubated with angioten-
sin II at 0 mol/L, 109 mol/L, 108 mol/L, 107 mol/L, and 106 mol/L,
respectively. N  6 in each group. The data are shown as mean 

SD.*P  0.05 vs. lane 1.
sion can be up-regulated in fibroblasts by a variety of
soluble factors, including interleukin-1, tumor necrosis
factor, epidermal growth factor, transforming growth fac-
tor-, phorbol esters, and retinoic acid [22]. TIMP-1 can
also be increased by angiotensin II in rat heart endothe-
lial cells [7].
The renin-angiotensin system is tightly correlated with
the function of proximal tubular cells [23, 24]. Local
RAS exist in proximal tubular cells and regulate the
functions of reabsorption and production of TGF-1
[25]. Angiotensin II has been well known to initiate mul-
tiple signaling pathways via its receptors [26–28]. How-
ever, it is unknown whether angiotensin II could induce
TIMP-1 expression in renal cells and which signaling
pathway mediated angiotensin II–induced TIMP-1 ex-
Fig. 7. Time course analysis of angiotensin II–induced DNA-STAT
binding. Cells were incubated with angiotensin II (107 mol/L) for 0
minutes (lane 1), 10 minutes (lane 2), 30 minutes (lane 3), 1 hour (lane
4), 2 hours (lane 5), and 3 hours (lane 6), respectively. Angiotensin II–
induced STAT-DNA binding activity peaked twice at 10 minutes and
120 minutes of incubation, respectively. N  6 in each group. The data
are shown as mean 
 SD. *P  0.05 vs. lanes 1, 3, and 4. STAT is
signal transducer and activator of transcription.
pression. STAT signal pathway is recently characterized
regulating many cellular events triggered by TGF,
TNF, erythropoietin, and interleukins [29]. JAK-STAT
is an important signal transduction pathway that can be
activated by angiotensin II to promote the proliferation
of mesangial cells and muscular cells [12, 30]. We re-
ported that STAT1 and STAT3 mediated thrombin-
induced up-regulation of TIMP-1 in human glomerular
mesangial cells [8]. The present study was designed to
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Fig. 8. Specificity analysis of DNA-STAT binding. Cells were har-
vested after being incubated with 107 mol/L angiotensin II for 3 hours.
A 50-fold molar excess of unlabeled STAT and NF	B probes was added
30 minutes before the addition of the labeled common probe for both
STAT1 and STAT3. Lane 1 shows 0 mol/L angiotensin II; lane 2 shows
107 mol/L angiotensin II; lane 3 shows 107 mol/L angiotensin II plus
excess unlabeled STAT probe; and lane 4 shows 107 mol/L angiotensin
II plus excess unlabeled NF	B probe. N  5 in each group. The data
are shown as mean 
 SD. * P  0.05 vs. lanes 2 and 4. STAT is signal
transducer and activator of transcription.
further test whether angiotensin II could induce TIMP-1
expression in human renal proximal tubular epithelial
cells, and whether this induction is mediated through the
STAT pathway.
It has been reported that angiotensin II could stimu-
late TIMP-1 expression in both cardiac fibroblasts and
endothelial cells [7, 31]. Our results demonstrated that
angiotensin II up-regulated TIMP-1 gene expression in
cultured proximal tubular epithelial cells. This effect was
both dose- and time-dependent, which could be blocked
by the AT1 receptor antagonist valsartan, but not by the
AT2 receptor antagonist PD123319. In addition, we also
found that angiotensin II could boost STAT-DNA bind-
ing activity in a dose-dependent manner and with a bi-
phasic time course in tubular epithelial cells. It has been
reported that granulocyte colony-stimulating factor
(G-CSF) could also induce biphasic activation of STAT3
binding to DNA [32]. In addition, angiotensin II has
been demonstrated to be able to induce biphasic STAT91-
DNA binding in both cardiac fibroblasts and CHO-K1
Fig. 9. Supershift assay to identify the components of activated STAT
proteins. Cells were harvested after being incubated with 107 mol/L
angiotensin II for 3 hours. The rabbit polyclonal anti-STAT1 (Sc-345X)
antibody or anti-STAT3 (Sc-482X) antibody was added 30 minutes
before the addition of the labeled STAT probe. Lane 1 shows 0 mol/L
angiotensin II; lane 2 shows 107 mol/L angiotensin II; lane 3 shows
107 mol/L angiotensin II plus anti-STAT1 antibody; and lane 4 shows
107 mol/L angiotensin II plus anti-STAT3 antibody. STAT is signal
transducer and activator of transcription.
cells, with initial induction at 15 to 30 minutes, and maxi-
mal induction around 2 to 3 hours. The biphasic activa-
tion of STAT3-DNA binding activity suggested that the
initial stimulus by angiotensin might induce a secondary
factor that in turn activates STAT3 [33]. However, the
exact mechanisms of biphasic activation remain to be
elucidated.
The STATs pathway-regulated gene transcription in-
volves activation by tyrosine phosphorylation of the
DNA binding factor SIF in the cytoplasm, its nuclear
translocation, and interaction with the regulatory ele-
ment sis-inducing element (SIE). Wagner et al [34] found
that conditioned media from v-sis transformed normal
rat kidney (NRK) cells rapidly induced a DNA binding
protein which bound to a conserved sequence upstream
of the human c-fos gene, and that purified recombinant
c-sis/platelet-derived growth factor (PDGF) could in-
duce this binding activity, which they termed SIF. SIF is
a complex of proteins containing members of the STAT
family of transcription factors [6]. Our data were consis-
tent with both the finding by Omura et al [35] that angio-
tensin II promoted STAT3 activity through AT1 in myo-
cardium of rats and the finding by Ali et al [36] that
angiotensin II promoted STAT1 activity through AT1
in COS-7 cells, but were in contrast to the finding by
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Fig. 10. Angiotensin II receptor blocking assay for DNA-STAT bind-
ing. Cells were harvested after being incubated with 107 mol/L angio-
tensin II for 3 hours. Valsartan (106 mol/L) and 106 mol/L PD123319
were incubated with 107 mol/L Ang II, respectively. Lane 1 shows 0
mol/L angiotensin II; lane 2 shows 107 mol/L angiotensin II; lane 3
shows 107 mol/L angiotensin II plus AT1 receptor antagonist valsartan
(106 mol/L); and lane 4 shows 107 mol/L angiotensin II plus AT2
receptor antagonist PD123319 (106 mol/L). N  5 in each group. The
data are shown as mean 
 SD.*P  0.05 vs. lanes 2, 4. STAT is signal
transducer and activator of transcription.
Seebach et al [12] that angiotensin II promoted STAT1
activity through AT2 in fetal mesangial cells. We recently
reported that STAT1 and STAT3 were involved in
thrombin-induced expression of TIMP-1 gene in cul-
tured human mesangial cells [8]. In the present study,
we further demonstrated that the major DNA-binding
components that were involved angiotensin-induced
TIMP-1 expression were heterodimers STAT3/STAT1.
CONCLUSION
Our study demonstrated that both STAT1 and STAT3
can be activated by angiotensin II and are involved, at
least in part, in angiotensin II–induced TIMP-1 expres-
sion in human renal proximal tubular epithelial cells,
implicating the potential participation of STAT signaling
pathway in the pathogenesis of tubulointerstitial fibrosis.
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Fig. 11. STAT 1 and STAT 3 antisense oligonucleotides inhibited an-
giotensin II–induced TIMP-1, mRNA, and protein expressions in hu-
man renal proximal tubular epithelial cells. (A ) Representative North-
ern blotting results. (B ) Density ratio of TIMP-1 to -actin mRNA
expressions. (C ) Representative Western blotting result. Cells were
incubated in the serum-free DMEM medium containing 3 mol/L anti-
sense oligonucleotides in 10 mg/mL lipofectin for 10 hours before the
incubation with angiotensin II for 3 hours. As control, cells received
serum-free DMEM medium containing lipofectin with or without 3
mol/L sense or scrambled oligonucleotides. Lane 1 shows angiotensin II
(0 mol/L); lane 2 shows angiotensin II (107 mol/L); lane 3 shows STAT3
antisense (3 mol/L); lane 4 shows STAT3 antisense (3 mol/L) plus
angiotensin II (107 mol/L); lane 5 shows STAT3 sense (3 mol/L) plus
angiotensin II (107 mol/L); lane 6 shows STAT1 antisense (3 mol/L);
lane 7 shows STAT1 antisense (3 mol/L) plus angiotensin II (107
mol/L); lane 8 shows STAT1 sense (3 mol/L) plus angiotensin II (107
mol/L); lane 9 shows scrambled oligonucleotide (3 mol/L); and lane
10 shows scrambled oligonucleotide (3 mol/L) plus angiotensin II
(107 mol/L). N  6 in each group. The data are shown as mean 
 SD.
*P  0.05 vs. lanes 1, 3, 4, 6, 7, and 9.
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